Oncologic Samples

The category Oncologic Samples encompasses diverse human biospecimens of benign, in situ and malignant neoplasm samples like Leukaemia, Lymphoma, Breast, Brain, Eye, Lung, Pancreatic, Prostate, Skin or Uterus Cancer. Procurement takes place from consented donors under strict ethical standards. You can use our filter functions to perform complex searches according to laboratory parameters, disease in clear name or ICD-10 code, patient annotation, such as age, gender, BMI and ethnicity. If you do not find the samples you are looking for, please contact us.

Available filters
-
-
1,928 Products

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 84
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
84 Years
BMI:
26.7 kg/m²
Weight:
65 kg
Height:
156 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Actrapid
  • Carmen
  • Moxonidin
  • Protaphane
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • bisoprolol (Dosages: 2not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin
  • omeprazole (Dosages: 20mg)
  • simvastatine (Dosages: 20mg)
  • valsartan (Dosages: 160mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 154 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 94 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.95 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.7 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 285 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 115 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 35 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 40 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.4 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 67 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289380
1.1 mL ($47.44)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Androcur
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
78 Years
BMI:
22.8 kg/m²
Weight:
62 kg
Height:
165 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Androcur (Dosages: 10mg)
  • Gynokadin (Dosages: 7not specified)
  • Kalinor
  • Novaminsulfon
  • Pantozol (Dosages: 40not specified)
  • acetylsalicylic acid (ASA) (Dosages: 101not specified)
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 89 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 77 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.2 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.9 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 633 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 80 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 26 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 30 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.6 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289376
1.2 mL ($51.75)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Female Age: 72
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
72 Years
BMI:
26.6 kg/m²
Weight:
68 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • Digimerck
  • acetylsalicylic acid (ASA) (Dosages: 103not specified)
  • bisoprolol (Dosages: 5mg)
  • ciprofloxacin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 161 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 26 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.7 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 33.7 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 105 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 116 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 79 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 163 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 20 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.6 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 29 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307943
0.9 mL ($38.81)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Addel
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
Gender:
Female
Age:
59 Years
BMI:
24.8 kg/m²
Weight:
70 kg
Height:
168 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Addel
  • Aminoven
  • Cernevit
  • L-thyroxine
  • Meronem
  • Pantozol
  • bisoprolol
  • lercanidipine
  • metoclopramide
  • potassium
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 283 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.2 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 216.1 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 183 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 61 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 49 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.5 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 41 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL ($17.25)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C24.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
78 Years
BMI:
24.3 kg/m²
Weight:
67 kg
Height:
166 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil (Fenistil dry)
  • L-thyroxine (Dosages: 25not specified)
  • Ramipril (Dosages: 5not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25not specified)
  • pantoprazole (Dosages: 40not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 299 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 214 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 12.02 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 0.8 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 164 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 92 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 235 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 110 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 37 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 13.9 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 703 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308307
0.4 mL ($17.25)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 54
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
L-thyroxine
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
54 Years
BMI:
31.7 kg/m²
Weight:
96 kg
Height:
174 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • L-thyroxine (Dosages: 100not specified)
  • Lactrase
  • Pantozol (Dosages: 40mg)
  • Quetiapin (Dosages: 25mg)
  • RamiLich (Dosages: 5mg)
  • antidepressants
  • fluoxetine (Dosages: 20mg, Fluoxetin Neumax)
  • sedative
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 170 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 37 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 16.71 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.5 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 239 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 172 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 59 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 50 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 45 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.8 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 79 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289860
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 58
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
58 Years
BMI:
22.3 kg/m²
Weight:
63 kg
Height:
168 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 2mg)
  • Pulmicort
  • Verapamil (Dosages: 120mg)
Therapy:
  • hemithyreoidectomy
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 57 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 91 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.71 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 108.8 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 18 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 79 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 35 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 22 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 36 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.7 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 47 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307939
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 75
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Clexane
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
75 Years
BMI:
31.6 kg/m²
Weight:
82 kg
Height:
161 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Clexane (active agent: Enoxaparin sodium)
  • L-thyroxine
  • Lantus
  • Metoprolol
  • Nitrendipin
  • Ramipril
  • Tromcardin
  • hydrochlorothiazide (HCT)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 99 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 42 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.78 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 11.9 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 55 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 156 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 33 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 27 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 61 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.3 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 27 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289861
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - D37.70

Donor:
Gender: Male Age: 74
Diagnosed disease:
D37.70 - T2, N0, M0, stage IB, resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
74 Years
BMI:
22.5 kg/m²
Weight:
69 kg
Height:
175 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • D37.70
Medication:
  • Actrapid
  • Metoprolol (Dosages: 47not specified)
  • Moxonidin (Dosages: 0.6not specified)
  • Ramipril (Dosages: 5not specified)
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • insulin
  • simvastatine (Dosages: 20not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 72 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 84 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.26 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.1 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 72 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 149 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 92 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 45 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 36 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.6 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 48 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307896
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 64
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
L-thyroxine
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
64 Years
BMI:
28.4 kg/m²
Weight:
70 kg
Height:
157 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • L-thyroxine
  • antidepressants
  • metformin
  • omeprazole
  • paroxetine
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 75 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 38 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.25 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 17.5 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 24 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 175 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 27 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 36 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 81 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.5 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 26 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289848
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 56
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M1 (not specified)
Medication:
Lantus
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
56 Years
BMI:
23 kg/m²
Weight:
68 kg
Height:
172 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M1 (not specified)
Medication:
  • Lantus
  • Lasix (Dosages: 401not specified)
  • Pantozol (Dosages: 40mg)
  • fentanyl
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 413 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 13 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 2.18 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 19.2 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 246 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 126 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 16 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 23 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 49 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 5.1 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 7 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307912
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 67
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
67 Years
BMI:
24.2 kg/m²
Weight:
65 kg
Height:
164 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • ciprofloxacin
  • hydrochlorothiazide (HCT)
  • lisinopril
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 212 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 18 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 13.22 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 8932 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 113 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 203 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 147 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 119 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 74 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 9 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 20 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307963
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 80
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - stage III, non-resectable (not specified)
Medication:
Fluvastatin
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
80 Years
BMI:
27.7 kg/m²
Weight:
80 kg
Height:
170 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - stage III, non-resectable (not specified)
Medication:
  • Fluvastatin (Dosages: 80mg)
  • Metoprolol (Dosages: 47not specified)
  • Moxonidin
  • Telmisartan
  • acetylsalicylic acid (ASA) (Dosages: 300mg)
  • hydrochlorothiazide (HCT)
  • lercanidipine (Dosages: 10mg)
  • metamizole (Dosages: 1g)
  • pantoprazole (Dosages: 40mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 110 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 56 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 1.19 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 23.7 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 95 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 109 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 48 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 42 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 41 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.7 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 44 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307918
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Male Age: 64
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T4, N0, M0, stage III, non-resectable (not specified)
Medication:
Lantus
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
64 Years
BMI:
21.6 kg/m²
Weight:
67 kg
Height:
176 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T4, N0, M0, stage III, non-resectable (not specified)
Medication:
  • Lantus
  • Metoprolol (Dosages: 47not specified)
  • Nitrendipin (Dosages: 20mg)
  • acetylsalicylic acid (ASA) (Dosages: 100mg)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 103 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 38 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.7 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 0.6 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 60 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 212 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 16 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 24 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 49 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.1 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 5 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289787
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Female Age: 61
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Gabapentin
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
61 Years
BMI:
22.5 kg/m²
Weight:
48 kg
Height:
146 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - M1, stage IV, non-resectable (not specified)
Medication:
  • Gabapentin
  • Movicol
  • Novamin
  • Ossofortin
  • Targin
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 62 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 76 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.29 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1815 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 68 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 93 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 49 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 31 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 37 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.2 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 24 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289855
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Kreon
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
59 Years
BMI:
21.4 kg/m²
Weight:
50 kg
Height:
153 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Kreon (Dosages: 65000not specified)
  • Pantozol (Dosages: 40mg)
  • tilidine (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 86 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 1654 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.34 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 37.3 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 36 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 73 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 60 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 47 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 38 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 12.9 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 2773 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289828
0.8 mL ($34.50)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 64
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
64 Years
BMI:
27.3 kg/m²
Weight:
70 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • pantoprazole
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 113 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 37 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.88 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 676.1 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 292 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 139 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 208 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 152 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 39 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.6 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 32 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289844
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.1

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - stage III, non-resectable (not specified)
Medication:
Agomelatin
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
59 Years
BMI:
34.5 kg/m²
Weight:
94 kg
Height:
165 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - stage III, non-resectable (not specified)
Medication:
  • Agomelatin
  • L-thyroxine
  • antidepressants
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 50 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 38 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.48 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 24.3 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 19 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 98 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 14 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 18 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 45 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.3 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 14 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289881
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C24.0

Donor:
Gender: Male Age: 63
Diagnosed disease:
C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
63 Years
BMI:
32.7 kg/m²
Weight:
99 kg
Height:
174 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • allopurinol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 194 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 76 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.3 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 20.5 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 216 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 127 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 80 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 63 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 37 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 12.8 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 51 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289843
0.9 mL ($38.81)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 69
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
69 Years
BMI:
24 kg/m²
Weight:
76 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil
  • Metohexal
  • Pantozol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 314 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 20.9 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 993.3 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 82 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 114 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 129 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 104 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 43 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 12.9 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 9 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308259
0.5 mL ($21.56)
Available ($225.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Hemogl... - C25.2

Donor:
Gender: Male Age: 82
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
Sortis
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
Gender:
Male
Age:
82 Years
BMI:
25.3 kg/m²
Weight:
73 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
  • Sortis
  • amlodipine
Therapy:
  • transplant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 75 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.5 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 407.8 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 49 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 24 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 31 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 14.7 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 22 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 12 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308273
0.5 mL ($21.56)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 62
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Pantozol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Male
Age:
62 Years
BMI:
20.3 kg/m²
Weight:
60 kg
Height:
172 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Pantozol
  • Ramipril
  • bisoprolol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 284 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 40 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.65 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1803 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 524 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 91 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 142 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 65 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 38 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 12.2 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 40 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289832
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 65
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
65 Years
BMI:
21.9 kg/m²
Weight:
71 kg
Height:
180 cm
Sample:
Matrix:
Urine
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
  • Candesartan/candesartan
  • Pantozol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 196 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 139 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 14.64 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1486 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 86 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 172 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 89 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 55 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 33 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.4 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 289 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307901
0.9 mL ($38.81)
Available ($225.00)

Human Serum - Anti-Thyroglobulin (aTg / TAK), Thyro... - E03.9

Donor:
Gender: Female Age: 51 Ethnic group: European/Caucasian
Diagnosed disease:
C64 - left (not specified)
Medication:
Cimicifuga
Parameter:
Anti-Thyroglobulin (aTg / TAK) Thyrotropin (TSH) Thyroxine free (fT4) Triglycerides Triiodothyronine free (fT3)
Donor:
Gender:
Female
Age:
51 Years
Ethnic group:
European/Caucasian
BMI:
27 kg/m²
Weight:
82 kg
Height:
173 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • depression
  • hypothyroidism [E03.9]
  • kidney cell carcinoma [C64] - left (not specified)
Medication:
  • Cimicifuga (Dosages: 2/day)
  • L-Thyrox (Dosages: 50µg, manufacturer: Hexal)
  • Remergil (Dosages: 15mg)
  • escitalopram (Dosages: 20mg)
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 28.1 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 50.85 IU/mL
Source: this donation
< 100.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Anti-Thyroglobulin (aTg / TAK)
Qual:
Quant: 460.2 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 3.17 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine free (fT4)
Qual:
Quant: 10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triglycerides
Qual: negative
Quant: 1.48 mmol/L
Source: this donation
< 2.25 mmol/L
Method: not specified
System: not specified Beckman Coulter
Triiodothyronine free (fT3)
Qual:
Quant: 2.7 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH341789
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C18.6

Donor:
Gender: Male Age: 66 Ethnic group: European/Caucasian
Diagnosed disease:
C18.6 - Malignant neoplasm of descending colon
Medication:
Hygroton
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
66 Years
Ethnic group:
European/Caucasian
BMI:
34 kg/m²
Weight:
104 kg
Height:
176 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of descending colon [C18.6]
Medication:
  • Hygroton (Dosages: 25mg/day, active agent: chlorthalidone)
  • Metex (Dosages: 125mg/week)
  • Prednisolon (Dosages: 2mg/day)
  • Simvabeta (Dosages: 10mg/day)
  • amlodipine (Dosages: 5mg/day)
  • bisoprolol (Dosages: 5mg/day)
  • hydroxychloroquine (Dosages: 400/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: < 8.00 IU/mL
Source: this donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 27.2 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 34.37 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 29 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292431
1 mL ($43.13)
Available ($225.00)

Human Serum - 25-Hydroxy-Vitamin D3 (Calcidiol) - B00.7

Donor:
Gender: Male Age: 67
Diagnosed disease:
D80.8 - Other immunodeficiencies with predominantly antibody defects
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Centromere Protein B (CENP-B) Anti-Histone Anti-Jo-1 (a-histidyl-tRNA synthetase) Anti-Mutated citrullinated Vimentin (MCV) Anti-Nucleosome Anti-PM-Scl Anti-Proliferating cell nuclear antigen (PCNA) Anti-RNP/Sm Anti-SS-A (Ro) ...
Donor:
Gender:
Male
Age:
67 Years
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Disseminated herpesviral disease [B00.7]
  • Other immunodeficiencies with predominantly antibody defects [D80.8]
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: positive
Quant: 24.5 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Centromere Protein B (CENP-B)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Histone
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Jo-1 (a-histidyl-tRNA synthetase)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 5.5 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Nucleosome
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Proliferating cell nuclear antigen (PCNA)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-RNP/Sm
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-A (Ro)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-A 52 kDa (Ro 52)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-B (La)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Scl-70 (a-DNA topoisomerase I)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 1 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-double-stranded DNA (dsDNA)
Qual: negative
Quant: 9.6 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-ribosomal P-Protein (ARPA)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Antimitochondrial Antibodies (AMA-M2)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Beta-CrossLaps (b-CTX)
Qual: negative
Quant: 0.324 ng/mL
Source: this donation
0.115 - 0.748 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Bone alkaline phosphatase (BAP)
Qual: negative
Quant: 23.9 µg/L
Source: this donation
5.70 - 32.90 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.65 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.16 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.17 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: negative
Quant: 14.2 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 16.8 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 4.9 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 4.8 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 5.7 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH319263
0.2 mL ($25.88)
Available ($225.00)

Human Serum - 25-Hydroxy-Vitamin D3 (Calcidiol), Os... - B02.9

Donor:
Gender: Female Age: 41
Diagnosed disease:
D80.9 - Immunodeficiency with predominantly antibody defects, unspecified
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bactericidal / Permeability Increasing Protein (BPI) Anti-Centromere Protein B (CENP-B) Anti-Gliadin IgG Anti-Histone Anti-Jo-1 (a-histidyl-tRNA synthetase) Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Nucleosome Anti-PM-Scl ...
Donor:
Gender:
Female
Age:
41 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Zoster without complication [B02.9]
  • Immunodeficiency with predominantly antibody defects, unspecified [D80.9]
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: positive
Quant: 29.4 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Bactericidal / Permeability Increasing Protein (BPI)
Qual: negative
Quant: 6.7 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Centromere Protein B (CENP-B)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Gliadin IgG
Qual: negative
Quant: 2 RU/mL
Source: this donation
< 25.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-Histone
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Jo-1 (a-histidyl-tRNA synthetase)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 9 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Myeloperoxidase (MPO)
Qual: negative
Quant: 1.3 U/mL
Source: this donation
< 5.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Nucleosome
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Proliferating cell nuclear antigen (PCNA)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Proteinase 3 (PR3)
Qual: negative
Quant: 1.1 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-RNP/Sm
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-A (Ro)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-A 52 kDa (Ro 52)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-SS-B (La)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Scl-70 (a-DNA topoisomerase I)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 20 IU/mL
Source: this donation
< 100 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: negative
Quant: 10 IU/mL
Source: this donation
< 50.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 1 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-double-stranded DNA (dsDNA)
Qual: negative
Quant: 6.5 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-ribosomal P-Protein (ARPA)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Antimitochondrial Antibodies (AMA-M2)
Qual: negative
Quant: -
Source: this donation
negative -
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Beta-CrossLaps (b-CTX)
Qual: negative
Quant: < 0.033 ng/mL
Source: this donation
0.112 - 0.738 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Bone alkaline phosphatase (BAP)
Qual: negative
Quant: 12.7 µg/L
Source: this donation
4.70 - 27.00 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.58 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.05 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.17 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: positive
Quant: 6.8 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 12.4 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 5.4 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 16.2 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 9.4 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
<